4//SEC Filing
SAPIRSTEIN JAMES 4
Accession 0001415889-21-003426
CIK 0001604191other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 5:07 PM ET
Size
8.9 KB
Accession
0001415889-21-003426
Insider Transaction Report
Form 4
SAPIRSTEIN JAMES
DirectorPRESIDENT AND CEO
Transactions
- Award
Stock options (right to buy)
2021-06-30+900,000→ 900,000 totalExercise: $0.85Exp: 2031-06-30→ Common Stock, par value $0.0001 per share (900,000 underlying) - Other
Stock options (right to buy)
2021-06-30−900,000→ 300,000 totalExercise: $0.85Exp: 2030-07-15→ Common Stock, par value $0.0001 per share (900,000 underlying)
Footnotes (3)
- [F1]On June 30, 2021, the board of directors of AzurRx BioPharma, Inc. (the "Company") rescinded and cancelled stock option awards previously made to Mr. Sapirstein on July 16, 2020 covering 900,000 shares under the Company's Amended and Restated 2014 Omnibus Equity Incentive Plan and granted new stock options under the Company's 2020 Omnibus Equity Incentive Plan, as amended and restated, on substantially similar terms to the rescinded stock options.
- [F2]The stock options vest with respect to 300,000 shares in 18 equal monthly installments over a term of 18 months beginning 19 months after the grant of such options on July 16, 2020, and with respect to the remaining shares, if at all, upon the achievement of certain performance targets. Vesting is conditioned on Mr. Sapirstein's continued employment by the Company on the applicable vesting date.
- [F3]The stock option vests (i) with respect to 300,000 shares over a term of 18 months in 18 equal monthly installments starting with the first monthly installment on February 16, 2022, (ii) with respect to 200,000 shares immediately, and (iii) with respect to 400,000 shares, if at all, upon the achievement of certain performance targets. Vesting is conditioned on Mr. Sapirstein's continued employment by the Company on the applicable vesting date.
Documents
Issuer
AzurRx BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001559509
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 5:07 PM ET
- Size
- 8.9 KB